COMP <GO>
AXGN vs MDT // RETURN ON INVESTED CAPITAL (ROIC)
Axogen Inc. (NASDAQ) VS. Medtronic plc. (NYSE) • 15-METRIC TALLY: AXGN 5
— MDT 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: MDT
LAST: $49.37 (-0.52%) • MKT CAP: $2.96B
roic
-2.60%
LAST: $96.54 (-0.59%) • MKT CAP: $124.22B
roic
7.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AXGN VS. MDT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AXGN | MDT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.30% | 65.00% | +9.30 | AXGN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -2.60% | 7.80% | -10.40 | MDT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 17.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.10% | 4.37% | -4.47 | MDT | /fcf-yield <GO> |
| Operating Margin | -3.50% | 17.80% | -21.30 | MDT | /operating-margins <GO> |
| Net Profit Margin | -7.00% | 0.00% | -7.00 | MDT | /net-margins <GO> |
| Revenue Growth (YoY) | 20.20% | 8.40% | +11.80 | AXGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.93% | -2.93 | MDT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 18.64 | 3.08 | +15.56 | AXGN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 9/9 | -3.00 | MDT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 74.3 | 61.8 | +12.50 | AXGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | 0.91 | +0.19 | AXGN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.96B | $124.22B | -$121.25B | MDT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AXGN REV | MDT REV | AXGN GROSS % | MDT GROSS % | AXGN FCF | MDT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $225.2M | $36.36B | 74.3% | 65.0% | -$2.9M | $5.43B |
| FY 2024 | $187.3M | $33.54B | 75.8% | 65.3% | $1.4M | $5.18B |
| FY 2023 | $159.0M | $32.36B | — | — | -$12.9M | $5.33B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AXGN // BETA 1.10
MDT // BETA 0.91